Erwinase Study in Patients With Acute Lymphoblastic Leukemia

Summary

The goal of this clinical research study is to allow doctors to use Erwinia L-Asparaginase (Erwinase®) as a replacement for patients who are allergic to E.coli L-asparaginase or Pegylated E.coli L-asparaginase as part of the treatment for acute lymphoblastic leukemia (ALL) or T or B cell lymphoma. This trial was part of a multi institutional effort by the drug company to make Erwinase available for use.

Timeline

Start

2007-05

Primary completion

2012-02

Completion

2012-02

Drugs

Indications